Beam-linked startup launches with an eye on the next generation of RNA drugs

cafead

Administrator
Staff member
  • cafead   Sep 07, 2022 at 10:52: AM
via Orbital Therapeutics, a Cambridge, Mass.-based biotechnology startup focused on RNA-based medicines, launched Wednesday with a research collaboration with gene editing company Beam Therapeutics.

article source
 

<